ArticleNew microbes and new infectionsPublished
An open-label phase II trial of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity
Regional connection
Verified Author affiliations on the Europe PMC record name GSK, Hospital of the University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source
- Institutions
- GSK, Hospital of the University of Pennsylvania, Penn Medicine
- Counties
- Montgomery County, Philadelphia County
Publication record
- Type
- Article
- Venue
- New microbes and new infections
- Published
- Topic
- Clinical care
- Subject terms
- Monoclonal antibodies; Immunocompromised host; Pre-exposure Prophylaxis; Covid-19
- PubMed ID
- 40893477
- PubMed Central ID
- PMC12395066
- Open access
- Yes, open
- Added to directory
- Source checked